SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,074,661 | -32.2% | 1,049,372 | +30.7% | 0.00% | 0.0% |
Q1 2024 | $4,535,453 | -0.3% | 802,735 | -24.3% | 0.00% | 0.0% |
Q4 2023 | $4,549,896 | +20.1% | 1,060,582 | -2.8% | 0.00% | 0.0% |
Q3 2023 | $3,787,127 | -25.9% | 1,091,391 | -0.7% | 0.00% | 0.0% |
Q2 2023 | $5,109,764 | -26.3% | 1,098,874 | -26.8% | 0.00% | -50.0% |
Q1 2023 | $6,932,832 | -20.4% | 1,500,613 | +39.3% | 0.00% | 0.0% |
Q4 2022 | $8,705,941 | +166648.5% | 1,077,468 | +14.6% | 0.00% | +100.0% |
Q3 2022 | $5,221 | +98.1% | 940,571 | +85.9% | 0.00% | 0.0% |
Q2 2022 | $2,636 | -99.9% | 506,060 | +25.8% | 0.00% | 0.0% |
Q1 2022 | $3,308,000 | -38.7% | 402,381 | +11.0% | 0.00% | 0.0% |
Q4 2021 | $5,395,000 | -12.4% | 362,553 | +11.2% | 0.00% | 0.0% |
Q3 2021 | $6,161,000 | +537.1% | 326,157 | +527.2% | 0.00% | – |
Q2 2021 | $967,000 | -42.1% | 52,006 | -29.1% | 0.00% | – |
Q1 2021 | $1,670,000 | -42.1% | 73,393 | -44.8% | 0.00% | -100.0% |
Q4 2020 | $2,885,000 | +1485.2% | 132,867 | +632.3% | 0.00% | – |
Q3 2020 | $182,000 | -42.2% | 18,144 | -55.3% | 0.00% | – |
Q2 2020 | $315,000 | +121.8% | 40,586 | +191.3% | 0.00% | – |
Q1 2020 | $142,000 | +11.8% | 13,934 | +20.9% | 0.00% | – |
Q4 2019 | $127,000 | -70.1% | 11,529 | -59.3% | 0.00% | – |
Q3 2018 | $425,000 | – | 28,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |